Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Biotechnology	59.35M	70.14M	138.59M	104.75M	-
Biotechnology Growth	-15.39%	-49.39%	32.30%	-	-
Novel Biotherapeutics	-	-	-	-	20.95M
Novel Biotherapeutics Growth	-	-	-	-	103.36%
Performance Enzymes	-	-	-	-	48.11M
Performance Enzymes Growth	-	-	-	-	-17.28%
Total	59.35M	70.14M	138.59M	104.75M	69.06M
Total Growth	-15.39%	-49.39%	32.30%	51.69%	0.87%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Australia, New Zealand, Southeast Asia, China (APAC)	-	-	-	-	25.45M
Australia, New Zealand, Southeast Asia, China (APAC) Growth	-	-	-	-	39.16%
United States, Canada, Latin America (Americas)	21.28M	13.73M	17.00M	23.48M	24.35M
United States, Canada, Latin America (Americas) Growth	54.94%	-19.22%	-27.60%	-3.58%	86.76%
Europe, Middle East, Africa (EMEA)	-	-	-	-	19.26M
Europe, Middle East, Africa (EMEA) Growth	-	-	-	-	-48.14%
Europe, Middle East, Africa (emea) (excl. Ireland & Switzerland)	5.16M	11.31M	10.14M	8.69M	-
Europe, Middle East, Africa (emea) (excl. Ireland & Switzerland) Growth	-54.37%	11.51%	16.73%	-	-
Australia, New Zealand, Southeast Asia, China (apac) (excl. China, India, Singapore)	4.41M	5.10M	4.45M	-	-
Australia, New Zealand, Southeast Asia, China (apac) (excl. China, India, Singapore) Growth	-13.62%	14.67%	-	-	-
Ireland	1.80M	500.00K	37.20M	1.40M	-
Ireland Growth	260.00%	-98.66%	2557.14%	-	-
Switzerland	3.40M	11.10M	9.20M	10.10M	-
Switzerland Growth	-69.37%	20.65%	-8.91%	-	-
China	9.80M	20.30M	48.60M	43.50M	-
China Growth	-51.72%	-58.23%	11.72%	-	-
India	7.30M	5.70M	8.80M	-	-
India Growth	28.07%	-35.23%	-	-	-
Singapore	6.20M	2.40M	3.20M	-	-
Singapore Growth	158.33%	-25.00%	-	-	-
Australia, New Zealand, Southeast Asia, China (apac) (excl. China)	-	-	-	17.59M	-
Total	59.35M	70.14M	138.59M	104.75M	69.06M
Total Growth	-15.39%	-49.39%	32.30%	51.69%	0.87%

Source: S&P Global Market Intelligence.